Drug Profile


Alternative Names: CBS 211A

Latest Information Update: 01 Nov 1996

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chauvin
  • Class Antiacnes; Antipsoriatics; Benzoic acids; Retinoids; Small molecules; Vitamins
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Corneal ulcer; Dry eyes

Most Recent Events

  • 01 Nov 1996 Discontinued-II for Corneal ulcer in France (Ophthalmic)
  • 01 Nov 1996 Discontinued-II for Dry eyes in France (Ophthalmic)
  • 13 Oct 1994 Phase-II clinical trials for Eye disorders in France (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top